Get ready for a revolutionary moment in the world of cell therapy as biotech trailblazers, big pharma, and immunology experts from around the globe gather at the 2nd Cell Therapy for Autoimmune Disease Summit! From December 2-4, 2024, this exclusive event will drive the future of innovation in autoimmune treatment.
As cell therapies continue to transform the landscape of chronic disease management, this summit is your gateway to the next wave of groundbreaking solutions. Join industry leaders and pioneers as they explore how cell therapies are pushing the boundaries of what’s possible for autoimmune diseases. This year’s summit offers deep insights into the long-term effects of CAR-Ts, overcoming regulatory hurdles, and optimizing patient access—the essential steps to revolutionizing care.
Featuring key figures like Chris Jewell from Cartesian Therapeutics, Samik Basu from Cabaletta Bio, and David Porter from the University of Pennsylvania, attendees will gain exclusive access to cutting-edge discussions on novel CAR-T, Treg, NKT, Gamma Delta T, In-Vivo, and T-cell engager approaches to cure autoimmune diseases. Learn from the best in the industry as they dive deep into the key opportunities and challenges shaping the future of cell therapies for autoimmune conditions.
Don’t miss out on your chance to be at the forefront of this transformative era in healthcare. Be part of the conversation that’s setting new standards in the autoimmune field. The 2nd Cell Therapy for Autoimmune Disease Summit is where innovation, collaboration, and strategy collide to create the therapies of tomorrow.
Join us and be a driving force in the evolution of cell therapies.
For more information on how to register and secure your place, visit our website: https://ter.li/5635wi